StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)

Close on Nov 18, 2026Market cap $13.64MP/E –Yield –

Genenta Science S.p.A. operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -€6.60M. The highest annual figure on record is -€4.62M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€6.60M–
FY2024Dec 31, 2024-€9.76M–
FY2023Dec 31, 2023-€11.73M–
FY2022Dec 31, 2022-€11.04M–
FY2021Dec 31, 2021-€5.69M–
FY2020Dec 31, 2020-€5.59M–
FY2019Dec 31, 2019-€4.62M–

More Genenta Science S.p.A. figures

See a number that looks wrong?